Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.

Coagulation activation and venous thromboembolism (VTE) are hallmarks of cancer; however, there is an unmet need of improved biomarkers for individualized anticoagulant treatment. The present sub-study of the RASTEN trial was designed to explore the role of coagulation biomarkers in predicting VTE r...

Full description

Bibliographic Details
Main Authors:	E Gezelius, A Flou Kristensen, P O Bendahl, Y Hisada, S Risom Kristensen, L Ek, B Bergman, M Wallberg, U Falkmer, N Mackman, S Pedersen, M Belting
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6226210?pdf=render

Similar Items

Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: Assessment of analytical and between‐subject variation
by: Søren Risom Kristensen, et al.
Published: (2022-01-01)

Epidemiology of Venous Thromboembolism After Second Cancer
by: Gade IL, et al.
Published: (2020-04-01)

Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty
by: Kevin Baker, et al.
Published: (2017-01-01)

Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism
by: Samuel Adediran, et al.
Published: (2017-01-01)

Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)

Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients
by: N. V. Vorobyev, et al.
Published: (2018-11-01)

Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease?
by: Juan Pablo Albornoz, et al.
Published: (2015-12-01)

The effect of pH on thrombin generation–An unrecognized potential source of variation
by: Søren Risom Kristensen, et al.
Published: (2020-02-01)

Reply to a letter from Jackson J et al: Effect of pH on thrombin activity measured by calibrated automated thrombinography
by: Søren Risom Kristensen, et al.
Published: (2020-08-01)

Effect of heparin for the prevention of venous thromboembolism in patients with spontaneous intracranial cerebral hemorrhage: a meta-analysis
by: Yifu Zhou, et al.
Published: (2024-05-01)

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
by: Pineo GF, et al.
Published: (2012-04-01)

Venous thromboembolism after lower extremity orthopedic surgery: A population‐based nationwide cohort study
by: Inger Lise Gade, et al.
Published: (2021-01-01)

VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY
by: I. E. Zazerskaya, et al.
Published: (2016-06-01)

Primary prevention of venous thromboembolism with low molecular weight heparins in surgical patients – 2024: Council of Experts resolution
by: А. S. Petrikov, et al.
Published: (2024-08-01)

Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
by: Lily Nguyen, et al.
Published: (2023-08-01)

What′s new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention?
by: Luca Masotti, et al.
Published: (2014-01-01)

Prevention of venous thromboembolic complications and heparin-induced thrombocytopenia in patient with acute inflammatory polyneuropathy (Guillain-Barre syndrome)
by: M. A. Piradov, et al.
Published: (2017-02-01)

Safety and efficacy of low-molecular-weight heparin in patients with acute venous thromboembolism postthrombolytic therapy as compared to unfractionated heparin: A systematic review and meta-analysis
by: Eman M. Mansory, et al.
Published: (2024-12-01)

Coagulation parameters correlate to venous thromboembolism occurrence during the perioperative period in patients with spinal fractures
by: Yong Jiao, et al.
Published: (2023-12-01)

Saponins as Modulators of the Blood Coagulation System and Perspectives Regarding Their Use in the Prevention of Venous Thromboembolic Incidents
by: Beata Olas, et al.
Published: (2020-11-01)

Venous thromboembolism
by: Wang Chunmei
Published: (2024-07-01)

A Case Report of Venous Thromboembolism with Heparin-induced Thrombocytopenia Characterized by Venous Limb Gangrene Treated with Integrated Traditional Chinese and Western Medicine
by: GONG Rui, ZHANG Yue, CHENG Zhixin, TANG Weihe
Published: (2023-02-01)

Validation of Postsurgical Venous Thromboembolism Diagnoses of Patients Undergoing Lower Limb Orthopedic Surgery in the Danish National Patient Registry
by: Galsklint J, et al.
Published: (2022-02-01)

Clinical applications of machine learning in the survival prediction and classification of sepsis: coagulation and heparin usage matter
by: Fei Guo, et al.
Published: (2022-06-01)

Low-molecular-weight heparin in the prevention of venous thromboembolism among patients with acute intracerebral hemorrhage: A meta-analysis.
by: Haizheng Li, et al.
Published: (2024-01-01)

Bleeding and venous thromboembolism events in cancer patients taking direct oral anticoagulants vs. low molecular weight heparin
by: Frank A. Lattuca, et al.
Published: (2023-03-01)

Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism
by: Liew, Ngoh Chin, et al.
Published: (2017)

Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19
by: Frydman, Galit H., et al.
Published: (2020)

Construction of nomogram model for risk of venous thromboembolism after spine surgery based on thromboelastography and coagulation indices
by: Yongtao He, et al.
Published: (2024-11-01)

Association between venous thromboembolism‐associated genetic variants, coagulation factor levels, and thrombin generation potential
by: Jihee Han, et al.
Published: (2024-02-01)

Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia
by: Lei Li PhD, et al.
Published: (2020-09-01)

Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy
by: Yang-Chao Zhao, et al.
Published: (2022-06-01)

Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
by: Julien Succar, et al.
Published: (2011-05-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
by: Khaled M. Musallam, et al.
Published: (2011-01-01)

Osteoporosis and venous thromboembolism
by: Irina Aleksandrovna Baranova, et al.
Published: (2011-02-01)

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01)

Hyperglycemia and Venous Thromboembolism
by: Neha Panchagnula, et al.
Published: (2024-09-01)

Venous anomalies and thromboembolism
by: Caroline Dix, et al.
Published: (2023-04-01)

Approach to: Venous Thromboembolism
by: Salima Ramdani
Published: (2022-10-01)